Professional Documents
Culture Documents
Patient-Centered Drug Study/ Analysis
Patient-Centered Drug Study/ Analysis
STUDENTS INFORMATION Name: DOMINO, NIKKI Y. Group: 1 (B) Agency/ Area: 5B WARD Inclusive Dates of Rotation: MARCH 3-5, 2014 Year and Section: 4 ACN Shift: 7AM-3PM Clinical Instructor: PROFESSOR CAYETANO
PATIENTS INFORMATION Name of Patient: PATIENT E6 Chief Complaint: Diagnosis: Age: Sex: M
DRUG INFORMATION Drug Classification: Anti-infectives, Anti-protozoals Generic Name: Metronidazole__________________ Dosage: Brand Name: Flagyl Route of Administration: PO MODE/ MECHANISM OF ACTION Disrupts DNA and protein synthesis in susceptible organisms Bactericidal, or amebicidal action
INDICATION
Amebicide in the management of amebic dysentery Hypersensitivity
CONTRAINDICATION
NURSING CONSIDERATIONS/ HEALTH TEACHINGS Assessment & Drug Effects Discontinue therapy immediately if symptoms of CNS toxicity develop. Monitor especially for seizures and peripheral neuropathy (e.g., numbness and paresthesia of extremities). Lab tests: Obtain total and differential WBC counts before, during, and after therapy, especially if a second course is necessary. Monitor for S&S of sodium retention, especially in patients on corticosteroid therapy or with a history of CHF. Monitor patients on lithium for elevated lithium levels. Report appearance of candidiasis or its becoming more prominent with therapy to physician promptly. Repeat feces examinations, usually up to 3 months, to ensure that amebae have been eliminated. Patient & Family Education Adhere closely to the established regimen without schedule interruption or changing the dose. Refrain from intercourse during therapy for trichomoniasis unless male partner wears a condom to prevent reinfection. Have sexual partners receive concurrent treatment. Asymptomatic trichomoniasis in the male is a frequent source of reinfection of the female. Prepared by: Evaluated by: Do not drink alcohol during therapy; may induce a disulfiram-type reaction Avoid alcohol or alcoholcontaining medications for at least 48 h after treatment is completed. Urine may appear dark or reddish brown (especially with higher than recommended doses). This appears to have no significance. Student Nuclinical rses Signature over Printed Name Clinical Instructors Signature over Printed Name DATE: DATE: Rating: Mode/ Mechanism of Action Indication and Contraindication Side Effect and Adverse Reaction Drug Interactions Nursing Considerations/ Health Teachings POINTS 15 15 15 15 40 SCORE